A recent study showed that the knockdown of SLC25A22 suppressed aspartate synthesis and reduced NADPH production via the tricarboxylic acid (TCA) cycle in colorectal cancer cells (Wong et al., 2016). Here, SLC25A22 is linked to colorectal cancer.